These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22362582)
21. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study. Bilinski K; Boyages J Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153 [TBL] [Abstract][Full Text] [Related]
22. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study. Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532 [TBL] [Abstract][Full Text] [Related]
23. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women. Murphy N; Strickler HD; Stanczyk FZ; Xue X; Wassertheil-Smoller S; Rohan TE; Ho GY; Anderson GL; Potter JD; Gunter MJ J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26232761 [TBL] [Abstract][Full Text] [Related]
24. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Eliassen AH; Spiegelman D; Hollis BW; Horst RL; Willett WC; Hankinson SE Breast Cancer Res; 2011 May; 13(3):R50. PubMed ID: 21569367 [TBL] [Abstract][Full Text] [Related]
25. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676 [TBL] [Abstract][Full Text] [Related]
26. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study. Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554 [TBL] [Abstract][Full Text] [Related]
27. Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study. Sofi NY; Jain M; Kapil U; Seenu V; R L; Yadav CP; Pandey RM; Sareen N J Steroid Biochem Mol Biol; 2018 Jan; 175():200-204. PubMed ID: 29137944 [TBL] [Abstract][Full Text] [Related]
28. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA; Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918 [TBL] [Abstract][Full Text] [Related]
29. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548 [TBL] [Abstract][Full Text] [Related]
30. 25-hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case-control versus nested case-control studies. Grant WB Anticancer Res; 2015 Feb; 35(2):1153-60. PubMed ID: 25667506 [TBL] [Abstract][Full Text] [Related]
31. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Woolcott CG; Wilkens LR; Nomura AM; Horst RL; Goodman MT; Murphy SP; Henderson BE; Kolonel LN; Le Marchand L Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):130-4. PubMed ID: 20056631 [TBL] [Abstract][Full Text] [Related]
32. Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study. Song M; Konijeti GG; Yuan C; Ananthakrishnan AN; Ogino S; Fuchs CS; Giovannucci EL; Ng K; Chan AT Cancer Prev Res (Phila); 2016 Aug; 9(8):664-72. PubMed ID: 27246684 [TBL] [Abstract][Full Text] [Related]
33. Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. Kim Y; Franke AA; Shvetsov YB; Wilkens LR; Cooney RV; Lurie G; Maskarinec G; Hernandez BY; Le Marchand L; Henderson BE; Kolonel LN; Goodman MT BMC Cancer; 2014 Jan; 14():29. PubMed ID: 24438060 [TBL] [Abstract][Full Text] [Related]
34. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S; Br J Cancer; 2007 Aug; 97(3):446-51. PubMed ID: 17622244 [TBL] [Abstract][Full Text] [Related]
35. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study. Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363 [TBL] [Abstract][Full Text] [Related]
36. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India. Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737 [TBL] [Abstract][Full Text] [Related]
37. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Abbas S; Chang-Claude J; Linseisen J Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430 [TBL] [Abstract][Full Text] [Related]
38. Serum 25-hydroxyvitamin D deficiency and increased risk of breast cancer among Korean women: a case-control study. Park S; Lee DH; Jeon JY; Ryu J; Kim S; Kim JY; Park HS; Kim SI; Park BW Breast Cancer Res Treat; 2015 Jul; 152(1):147-154. PubMed ID: 26037255 [TBL] [Abstract][Full Text] [Related]